Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX

NCT02338505 · Catholic University of the Sacred Heart · Updated 14 Jan 2015

What is being tested
Telelap ALF-X
For
Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis
Kind of study
Tests a treatment or device on volunteers. Phase 2.
Who can join
Ages 18 years to 90 years. About 50 people. The full rules are on the registry page.
Where
Italy
When
Starts or started Feb 2015, ends Feb 2016. Registered 14 Jan 2015.
Results
None posted yet.

In the researchers' words

Phase II prospective single-institutional study.
ClinicalTrials.gov, NCT02338505

Sites

  • Catholic University of Sacred Heart Rome,Rome, Rome, Italy